JDD in the Media

Topcials in Psoriasis Treatments

By January 21, 2020February 14th, 2020No Comments

Psoriasis is a chronic disease that can affect many areas of the body. The use of topical corticosteroids (TCS) is a common treatment, although long-term safety of TCS remains a concern.

A recent article in Dermatology Times cites a Journal of Drugs in Dermatology study which examines how Topical Halobetsol Propionate 0.01% lotion appears to “safely and quickly improve lower-extremity psoriatic lesions,” over typical TCS treatments.
“A post hoc analysis of data from phase 3 studies investigating the efficacy of halobetasol propionate 0.01% lotion for treating moderate-to-severe plaque psoriasis showed that the topical corticosteroid was associated with rapid improvement, and  findings should help dermatologists with treatment decisions for patients with disease involving leg lesions, said Neal Bhatia, M.D., director of clinical dermatology at Therapeutics Clinical Research, San Diego, and the lead author of the paper.”

At the conclusion of the eight-week treatment, the rate of success was significantly higher for patients randomized  to once-daily treatment with halobetasol 0.01% lotion compared with vehicle-treated controls (P<.001 for both comparisons).

View Article Now

You May Also Like

Atopic DermatitisCOVID 19JDD HighlightsJDD in the MediaPsoriasisThe Latest
January 14, 2022

JDD in the News: Medical Cannabis Products, S. aureus-Based Product for AD

By Allison Sit Practical Dermatology published an article, “Survey: Consumers Interested in Medical Cannabis Products for Inflammatory Skin Disorders,” about the January JDD study, “Consumer Perspectives on and Utilization of…
JDD HighlightsJDD in the MediaPsoriasisThe Latest
January 3, 2022

JDD in the News: Alternative Medicine & HS, Temporary Interruption of Biologics

By Allison Sit Healio recently reported on several JDD studies including one from the October JDD, “A Comparison of Alternative Medicine Users and Non-Users in Patients With Hidradenitis Suppurativa,” by…
AcneJDD HighlightsJDD in the MediaSkin of ColorThe Latest
July 15, 2021

JDD in the News: Vitamin D Supplementation, Acne in People of Color

By Allison Sit The Journal of Drugs in Dermatology is featured in the June issue of Dermatology Times. The publication included a 2020 JDD study in its article, “COVID-19 Increases…

Leave a Reply